Page last updated: 2024-09-04

dx 8951 and Lung Neoplasms

dx 8951 has been researched along with Lung Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (40.00)18.2507
2000's4 (40.00)29.6817
2010's0 (0.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Chen, C; Fu, G; Hu, W; Hu, YP; Hua, G; Liu, SH; Ma, L; Meng, T; Meng, X; Pan, R; Pu, J; Qian, Y; Shen, Y; Shi, J; Wang, L; Wang, M; Wang, Z; Weng, W; Zhang, H; Zhang, J; Zhang, Y; Zhao, Q; Zhou, B1
Chandarlapaty, S; Drago, JZ; Gupta, A1
Braybrooke, JP; Cheverton, P; Manegold, C; Mattson, K; Oyama, R; Ranson, M; Sekiguchi, M; Suzuki, M; Talbot, DC; Thatcher, N1
Ishii, M; Joto, N; Kuga, H; Minami, M; Mitsui, I; Tohgo, A1
Saijo, N2
Jimbo, T; Kumazawa, E; Ochi, Y; Tohgo, A1
Ishida, T; Mori, M; Nishio, K; Nomoto, T; Saijo, N1
Ejima, A; Imagawa, S; Ishii, M; Iwahana, M; Minami, M; Mitsui, I; Tohgo, A1
Inoue, K1

Reviews

3 review(s) available for dx 8951 and Lung Neoplasms

ArticleYear
New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
    Chest, 1998, Volume: 113, Issue:1 Suppl

    Topics: Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carbazoles; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Docetaxel; Glucosides; Humans; Irinotecan; Japan; Lung Neoplasms; Mitomycin; Mitomycins; Neoplasms, Experimental; Paclitaxel; Purine Nucleosides; Staurosporine; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine

1998
Preclinical and clinical trials of topoisomerase inhibitors.
    Annals of the New York Academy of Sciences, 2000, Volume: 922

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Colorectal Neoplasms; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Irinotecan; Lung Neoplasms; Topoisomerase I Inhibitors

2000
[Drug delivery systems for cancer chemotherapy].
    Nihon Geka Gakkai zasshi, 2002, Volume: 103, Issue:2

    Topics: Animals; Antineoplastic Agents, Phytogenic; Camptothecin; Clinical Trials as Topic; Drug Delivery Systems; Drug Design; Humans; Lung Neoplasms; Particle Size

2002

Trials

1 trial(s) available for dx 8951 and Lung Neoplasms

ArticleYear
Phase II study of exatecan mesylate (DX-8951f) as first line therapy for advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2003, Volume: 41, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Finland; Germany; Humans; Infusions, Intravenous; Japan; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Survival Analysis; Treatment Outcome; United Kingdom

2003

Other Studies

6 other study(ies) available for dx 8951 and Lung Neoplasms

ArticleYear
Antibody-Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer.
    Cancer discovery, 2023, 04-03, Volume: 13, Issue:4

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colon; Humans; Immunoconjugates; Irinotecan; Lung Neoplasms; Mutation; Protein Kinase Inhibitors; Receptor, ErbB-2; Topoisomerase I Inhibitors

2023
ADCs or: How I Learned to Stop Worrying and Love Chemotherapy.
    Cancer discovery, 2023, 04-03, Volume: 13, Issue:4

    Topics: Colon; Humans; Immunoconjugates; Love; Lung Neoplasms

2023
DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant.
    International journal of cancer, 1997, Aug-07, Volume: 72, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Small Cell; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Stability; Enzyme Inhibitors; Flow Cytometry; Humans; Irinotecan; Lung Neoplasms; Solubility; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured; Water

1997
Potent and broad antitumor effects of DX-8951f, a water-soluble camptothecin derivative, against various human tumors xenografted in nude mice.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Colonic Neoplasms; Humans; Irinotecan; Kidney Neoplasms; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Stomach Neoplasms; Subrenal Capsule Assay; Tumor Cells, Cultured

1998
Characterization of a human small-cell lung cancer cell line resistant to a new water-soluble camptothecin derivative, DX-8951f.
    Japanese journal of cancer research : Gann, 1998, Volume: 89, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Carcinoma, Small Cell; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Lung Neoplasms; Solubility; Topoisomerase I Inhibitors; Tumor Cells, Cultured; Water

1998
Growth inhibitory effect of a new camptothecin analog, DX-8951f, on various drug-resistant sublines including BCRP-mediated camptothecin derivative-resistant variants derived from the human lung cancer cell line PC-6.
    Anti-cancer drugs, 2000, Volume: 11, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Blotting, Western; Camptothecin; Carcinoma, Small Cell; Cisplatin; DNA Primers; DNA Topoisomerases, Type I; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Stability; Fluorouracil; Glutathione; Glutathione S-Transferase pi; Glutathione Transferase; Humans; In Vitro Techniques; Inactivation, Metabolic; Isoenzymes; Lung Neoplasms; Neoplasm Proteins; Reverse Transcriptase Polymerase Chain Reaction; Topoisomerase I Inhibitors; Tubulin; Tubulin Modulators; Tumor Cells, Cultured

2000